245 related articles for article (PubMed ID: 19909294)
1. Protective role of palmitoylethanolamide in contact allergic dermatitis.
Petrosino S; Cristino L; Karsak M; Gaffal E; Ueda N; Tüting T; Bisogno T; De Filippis D; D'Amico A; Saturnino C; Orlando P; Zimmer A; Iuvone T; Di Marzo V
Allergy; 2010 Jun; 65(6):698-711. PubMed ID: 19909294
[TBL] [Abstract][Full Text] [Related]
2. Palmitoylethanolamide reduces inflammation and itch in a mouse model of contact allergic dermatitis.
Vaia M; Petrosino S; De Filippis D; Negro L; Guarino A; Carnuccio R; Di Marzo V; Iuvone T
Eur J Pharmacol; 2016 Nov; 791():669-674. PubMed ID: 27720681
[TBL] [Abstract][Full Text] [Related]
3. Effects and mechanisms of aloperine on 2, 4-dinitrofluorobenzene-induced allergic contact dermatitis in BALB/c mice.
Yuan XY; Liu W; Zhang P; Wang RY; Guo JY
Eur J Pharmacol; 2010 Mar; 629(1-3):147-52. PubMed ID: 20006963
[TBL] [Abstract][Full Text] [Related]
4. Adelmidrol increases the endogenous concentrations of palmitoylethanolamide in canine keratinocytes and down-regulates an inflammatory reaction in an in vitro model of contact allergic dermatitis.
Petrosino S; Puigdemont A; Della Valle MF; Fusco M; Verde R; Allarà M; Aveta T; Orlando P; Di Marzo V
Vet J; 2016 Jan; 207():85-91. PubMed ID: 26639824
[TBL] [Abstract][Full Text] [Related]
5. The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide.
Lo Verme J; Fu J; Astarita G; La Rana G; Russo R; Calignano A; Piomelli D
Mol Pharmacol; 2005 Jan; 67(1):15-9. PubMed ID: 15465922
[TBL] [Abstract][Full Text] [Related]
6. Acute intracerebroventricular administration of palmitoylethanolamide, an endogenous peroxisome proliferator-activated receptor-alpha agonist, modulates carrageenan-induced paw edema in mice.
D'Agostino G; La Rana G; Russo R; Sasso O; Iacono A; Esposito E; Raso GM; Cuzzocrea S; Lo Verme J; Piomelli D; Meli R; Calignano A
J Pharmacol Exp Ther; 2007 Sep; 322(3):1137-43. PubMed ID: 17565008
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory activity of topical THC in DNFB-mediated mouse allergic contact dermatitis independent of CB1 and CB2 receptors.
Gaffal E; Cron M; Glodde N; Tüting T
Allergy; 2013 Aug; 68(8):994-1000. PubMed ID: 23889474
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoid 1 receptors in keratinocytes modulate proinflammatory chemokine secretion and attenuate contact allergic inflammation.
Gaffal E; Cron M; Glodde N; Bald T; Kuner R; Zimmer A; Lutz B; Tüting T
J Immunol; 2013 May; 190(10):4929-36. PubMed ID: 23585676
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of black rice bran against chemically-induced inflammation of mouse skin.
Choi SP; Kim SP; Kang MY; Nam SH; Friedman M
J Agric Food Chem; 2010 Sep; 58(18):10007-15. PubMed ID: 20731354
[TBL] [Abstract][Full Text] [Related]
10. [Effect of etoposide on allergic contact dermatitis induced by dinitrofluorobenzene and its action mechanism in mice].
Xie Q; Yan HL; Li YQ; Wang J; Wang JY
Yao Xue Xue Bao; 2007 Oct; 42(10):1050-3. PubMed ID: 18229610
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory Properties of Cannabidiol, a Nonpsychotropic Cannabinoid, in Experimental Allergic Contact Dermatitis.
Petrosino S; Verde R; Vaia M; Allarà M; Iuvone T; Di Marzo V
J Pharmacol Exp Ther; 2018 Jun; 365(3):652-663. PubMed ID: 29632236
[TBL] [Abstract][Full Text] [Related]
12. Evidence for a novel protective role of the vanilloid TRPV1 receptor in a cutaneous contact allergic dermatitis model.
Bánvölgyi A; Pálinkás L; Berki T; Clark N; Grant AD; Helyes Z; Pozsgai G; Szolcsányi J; Brain SD; Pintér E
J Neuroimmunol; 2005 Dec; 169(1-2):86-96. PubMed ID: 16188326
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E(2)-EP(3) signaling suppresses skin inflammation in murine contact hypersensitivity.
Honda T; Matsuoka T; Ueta M; Kabashima K; Miyachi Y; Narumiya S
J Allergy Clin Immunol; 2009 Oct; 124(4):809-18.e2. PubMed ID: 19541354
[TBL] [Abstract][Full Text] [Related]
14. Crucial role of phospholipase Cepsilon in induction of local skin inflammatory reactions in the elicitation stage of allergic contact hypersensitivity.
Hu L; Edamatsu H; Takenaka N; Ikuta S; Kataoka T
J Immunol; 2010 Jan; 184(2):993-1002. PubMed ID: 20007527
[TBL] [Abstract][Full Text] [Related]
15. Glutamine suppresses dinitrophenol fluorobenzene-induced allergic contact dermatitis and itching: inhibition of contact dermatitis by glutamine.
Jin ZW; Kim HK; Lee CH; Jung SW; Shin SJ; Im SY; Cho BH; Lee HK
J Dermatol Sci; 2012 Aug; 67(2):88-94. PubMed ID: 22727501
[TBL] [Abstract][Full Text] [Related]
16. Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha.
LoVerme J; Russo R; La Rana G; Fu J; Farthing J; Mattace-Raso G; Meli R; Hohmann A; Calignano A; Piomelli D
J Pharmacol Exp Ther; 2006 Dec; 319(3):1051-61. PubMed ID: 16997973
[TBL] [Abstract][Full Text] [Related]
17. Central administration of palmitoylethanolamide reduces hyperalgesia in mice via inhibition of NF-kappaB nuclear signalling in dorsal root ganglia.
D'Agostino G; La Rana G; Russo R; Sasso O; Iacono A; Esposito E; Mattace Raso G; Cuzzocrea S; Loverme J; Piomelli D; Meli R; Calignano A
Eur J Pharmacol; 2009 Jun; 613(1-3):54-9. PubMed ID: 19386271
[TBL] [Abstract][Full Text] [Related]
18. Phenylbutyrate suppresses distinct skin reactions that are enhanced by blockade of epidermal growth factor receptor signaling.
Chung YL; Pui NN
J Dermatol Sci; 2011 Dec; 64(3):163-73. PubMed ID: 21924869
[TBL] [Abstract][Full Text] [Related]
19. A Glucuronic Acid-Palmitoylethanolamide Conjugate (GLUPEA) Is an Innovative Drug Delivery System and a Potential Bioregulator.
Manzo E; Schiano Moriello A; Tinto F; Verde R; Allarà M; De Petrocellis L; Pagano E; Izzo AA; Di Marzo V; Petrosino S
Cells; 2021 Feb; 10(2):. PubMed ID: 33672574
[TBL] [Abstract][Full Text] [Related]
20. Palmitoylethanolamide modulates pentobarbital-evoked hypnotic effect in mice: involvement of allopregnanolone biosynthesis.
Sasso O; La Rana G; Vitiello S; Russo R; D'Agostino G; Iacono A; Russo E; Citraro R; Cuzzocrea S; Piazza PV; De Sarro G; Meli R; Calignano A
Eur Neuropsychopharmacol; 2010 Mar; 20(3):195-206. PubMed ID: 19864116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
